Stress, anxiety and depression easily mounts with a cancer diagnosis. The fears, uncertainties, and doubts can reign supreme, making cancer patients feel debilitated. Clinical sponsors are increasingly looking to what have traditionally been taboo substances to...
Psychedelics
Category
Dynamic University of Rio Grande do Norte Investigator Headed to University of Auckland to Discuss Research into Ayahuasca for Antidepressant Properties
Ayahuasca, an Amazonia indigenous culture psychedelic brew has been used for centuries in traditional spiritual medicine. It will now be the topic of a research-based discussion between Brazil’s University of Rio Grande do Norte and the University of Auckland in New...
Privately-Held Segal Trials Supports Usona Institute’s PSIL201 Clinical Trial Testing the Use of Psilocybin for Major Depression
Segal Trials, a privately held network of research sites throughout South Florida and South Carolina conducting Phase I-IV clinical trials, has been named one of seven sites to initiate a Phase II study of psilocybin—a psychedelic prodrug compound—for major depressive...
Center for Psychedelic Research Opens at Johns Hopkins Medicine
Johns Hopkins has opened The Center for Psychedelic and Consciousness Research in the nation’s first-ever research center to study the use of psychedelic substances as medicine for a range of mental health ailments, including addiction, depression, and PTSD. With $17...